A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Clinical trial NCT02161406 · COMPLETED

Trial details

NCT number: NCT02161406
Sponsor: Dinesh Khanna, MD, MS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Cutaneous Systemic Sclerosis

Start date: 2014-09-01
Primary completion: 2018-09-12
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.